ghmpnb | 20815
MPN Panel Mutations (blood)
Keywords:
ASXL1
BCOR
CALR
CBL
CEBPA
CSF3R
DNMT3A
ET
ETNK1
EZH2
Essential thrombocythaemia
IDH1
IDH2
JAK2
KIT
KRAS
MPL
MPN
Myeloproliferative neoplasms NGS
NF1
NPM1
NRAS
PHF6
PMF
PMF
PPM1D
PTPN11
PV
Polycythaemia vera
RUNX1
SETBP1
SF3B1
SH2B3
SRSF2
STAT5B
TET2
TP53
U2AF1
ZRSR2
primary myelofibrosis
Status
| Material |
|
||
|---|---|---|---|
| Hint |
ASXL1, BCOR, CALR, CBL, CEBPA, CSF3R, DNMT3A, ETNK1, EZH2, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NF1, NPM1, NRAS, PHF6, PPM1D, PTPN11, RUNX1, SETBP1, SF3B1, SH2B3, SRSF2, STAT5B, TET2, TP53, U2AF1, ZRSR2 | There is a possibility of excess information occurring with this analysis. This will be communicated, unless it is noted otherwise when placing the order. | Since in rare cases there may also be indications of hereditary changes, the GUMG (Federal Law on Genetic Testing in Humans) provides for the patient to be informed accordingly (see www.viollier.ch/en/SGMG_consent). |
||
| Min. volume | 4 mL | ||
| Stability |
Stability
1 day / 18-25°C; 4 days / 2-8°C
|
||
| Duration | 5 days | ||
| Frequency | 2 x per week | ||
| Method | Next Generation Sequencing |
Price/Rate
| Price |
Price
CHF 2’554.90
|
|---|---|
| Rate |
Rate
2'554.90 TP
|
